Journal of the Korean Ophthalmological Society 1996;37(3):411-417.
Published online March 1, 1996.
Clinical Experiences of Hydroxyapatite Implant.
Soon Jae Hong, Woo Chan Park, Sae Heun Rho
Department of Ophthalmology, College of Medicine, Dong-A University, Pusan, Korea.
Hydroxyapatite 삽입물의 임상 결과
홍순재(Soon Jae Hong),박우찬(Woo Chan Park),노세현(Sae Heun Rho)
Abstract
The hydroxyapatite has been used as an orbital implant for reconstruction after enucleation or evisceration. It has been known to be a biocompatible and nontoxic implant with good fibrovascular ingrowth, few postoperative complications, excellent prosthesis motility, and good cosmesis. We performed 36 cases of hydroxyapatite implantation with enucleation or evisceration from July 1992 to August 1994. The mean follow-up period was 7.4 months(range, 4 to 13 months). There were nine cases of implant exposure. three cases of peg extrusion, three cases of superficial conjunctival wound dehiscence, and one case of granulation tissue overgrowth. There was no infection of implant. Improving the postoperative results and reducing the postoperative complications, it requires proper surgical techniques including the selection of adequate implant size and good doctor-patient relationship.
Key Words: Enucleation;Evisceration;Hydroxyapatite Implantation;Implant Exposure


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next